At Charlie Kirk’s memorial service in Arizona, former President Donald Trump shifted from mourning his close ally to making a bold promise about a major medical announcement.
Speaking to the packed crowd at State Farm Stadium on September 21, Trump described Kirk, who had been shot and killed at just 31 years old, as “one of the brightest lights of our times” and “a giant of his generation.” He condemned the suspected shooter, calling him a “radicalised, cold-blooded monster,” before surprising many by turning the conversation to science and health.
Trump told the audience that the very next day he would be standing alongside Health Secretary Robert F. Kennedy Jr. and Dr. Mehmet Oz to deliver what he called the “biggest medical announcement in the history of the country.
He claimed that new findings could lead to an answer for autism, an issue he said he had been pushing officials to prioritize. Trump added that the announcement would focus on both prevention and treatment, insisting that families would find the news “amazing.”
According to reports, the upcoming press conference will discuss research suggesting a possible link between pregnant women using acetaminophen—commonly known as Tylenol in the U.S.—and a higher risk of autism in children.
While the FDA currently considers Tylenol safe during pregnancy, recent studies from institutions like Mount Sinai and Harvard have raised concerns about potential risks when the medication is taken early in pregnancy. The Trump administration is expected to advise caution, recommending that pregnant women avoid using the drug unless treating a fever.
The announcement will also highlight a potential treatment. Officials are expected to discuss leucovorin, a form of folinic acid usually given to cancer patients during chemotherapy or used to treat vitamin B9 deficiency. Early clinical trials suggested that autistic children who received leucovorin showed significant improvements in language and communication. Trump and Kennedy are expected to present it as a promising option for families seeking help.
This development comes months after RFK Jr. launched a wide-reaching project aimed at identifying the causes of autism. His plan involves analyzing private medical data from national and commercial databases, with the goal of piecing together a clearer picture of what drives the condition.
Kennedy has said that September would mark a turning point, claiming researchers would finally understand and be able to reduce autism risks. However, Kennedy himself has been a controversial figure in medical debates, at one point admitting that Americans “probably shouldn’t be taking medical advice” from him and acknowledging that his views on vaccines are not a substitute for scientific consensus.
Trump’s promise of a historic medical revelation has sparked both curiosity and skepticism. Supporters see it as an ambitious step toward addressing a condition that has deeply affected families across the country. Critics, however, warn that politicizing scientific research could undermine trust and spread misinformation. For now, all eyes are on today’s conference, where Trump, Kennedy, and Oz are expected to lay out their case for what they describe as a medical breakthrough.
